Tocik Z, Earl R A, Beránek J
Nucleic Acids Res. 1980 Oct 24;8(20):4755-61. doi: 10.1093/nar/8.20.4755.
1-O-Acetyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranose (I) was reacted with iodotrimethylsilane (II) and the product, the glycosyl iodide, was coupled with silylated uracil to afford 1-(2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)uracil (III; 89%), with silyated cytosine to afford, on subsequent acetylation, 1-(2,3,5-tri-O-benzoyl-beta-0D-ribofuranosyl)-4-acetamido-2-(1H)-pyrimidinone (IVb; 81%), and with chloromercuri-N-benzoyl-adenine to afford Va and on subsequent debenzoylation, adenosine (Vb; 49%).
1 - O - 乙酰基 - 2,3,5 - 三 - O - 苯甲酰基 - β - D - 呋喃核糖(I)与碘代三甲基硅烷(II)反应,所得产物糖基碘与硅烷化的尿嘧啶偶联,得到1 - (2,3,5 - 三 - O - 苯甲酰基 - β - D - 呋喃核糖基)尿嘧啶(III;产率89%);与硅烷化的胞嘧啶偶联,随后乙酰化得到1 - (2,3,5 - 三 - O - 苯甲酰基 - β - D - 呋喃核糖基) - 4 - 乙酰氨基 - 2 - (1H) - 嘧啶酮(IVb;产率81%);与氯汞基 - N - 苯甲酰基腺嘌呤反应得到Va,随后脱苯甲酰基得到腺苷(Vb;产率49%)。